InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by SUSAN BOBULSKY. Officer active across 1 company, notably Adaptive Biotechnologies Corporation. Cumulatively, 2 disclosures have been recorded. History available since 25 June 2026. The latest transaction was filed on 1 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations